Supplementary Figure 4 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer | Synapse
Supplementary Figure 4 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Figure 4. RAS/RAF co-altered, HER2 amplified CRC reflects a unique genomic subset with HER2 intratumoral heterogeneity.